Atlas Trials

Tolerability and Immunogenicity Study of FLUVAL P H1N1 Flu Vaccine of Omninvest in Children and Adolescents

Clinical trial NCT01407978 · COMPLETED

Trial details

NCT number
NCT01407978
Sponsor
Fluart Innovative Vaccine Ltd, Hungary
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Novel 2009 Influenza H1N1Influenza, Human
Start date
2009-08-01
Primary completion
2010-03-01
Enrollment
58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.